Ken-ichi Hatanaka - Concepedia

Author

Ken-ichi Hatanaka

Also Known As

K Hatanaka, K. Hatanaka, Ken-ichi Hatanaka

Publications

177

Citations

H-Index

Concepts

All Affiliations

Ken-ichi Hatanaka is an author at Astellas Pharma (Japan) specializing in medicine, drug discovery, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	160
2	Biochemistry	2	2	89
3	Social Sciences	1	1	26
4	Neurology	1	1	26
5	Neuroscience	1	1	26

Ken-ichi Hatanaka

Publications

160

Citations

H-Index

Page 1

	Year	Citations
Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou, European Journal of Pharmacology BiochemistryFunctional SelectivityMedicineMechanism Of ActionPharmacotherapy	2003	52
Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity Ken-ichi Hatanaka, Tamako Nomura, Koichi Hidaka, Neuropharmacology BiochemistryMedicinePsychotropic MedicationNeuropeptide ReceptorNeuropharmacology	1996	37
Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists Itsuro Shimada, Kyoichi Maeno, Kenichi Kazuta, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicine5-Ht2c Receptor AgonistsMechanism Of ActionEthylamine Derivatives	2007	35
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex Ken-ichi Hatanaka, Shin‐ichi Yatsugi, Tokio Yamaguchi European Journal of Pharmacology Acute TreatmentNeurophysiologyNeuroanatomyPhysiologyNeuroendocrine Mechanism	2000	26
Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists Itsuro Shimada, Kyoichi Maeno, Yutaka Kondoh, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicine5-Ht2c Receptor AgonistsPharmacological AgentBenzazepine Derivatives	2007	10

Page 1